Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GoGoVax: 4CMenB (Bexsero) for Gonorrhea Prevention in Gay and Bisexual Men
NCT04415424Phase 3Active, not recruiting
- Sponsor
- The Kirby Institute
- Start
- Jul 2021
- Primary completion
- Jun 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal group B vaccine in gonorrhea, sponsored by The Kirby Institute. Started Jul 2021; status: active, not recruiting.
02
Drugs
meningococcal group B vaccine
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT04415424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04415424.